Challenging the Mental Health Drug Business

Richard Wolff Apr 1, 2011

Challenging the Mental Health Drug Business by elizabeththenderson

The drug industry operates right at the juncture of economics and psychology, and this is especially true of its hugely profitable drugs for mental health problems. We discuss who benefits and who loses when drugs replace the therapeutic relationship between patient and psychotherapist, when treating health problems at great cost takes precedence over the less costly prevention of those problems.

This podcast was originally posted on Richard Wolff’s blog,

Comments are closed.

Ivermectin for Humans

Winter Fund Drive

This is a reader-supported publication. Once a year we appeal to you to contribute to this work.  We need to raise $40,000 to keep going strong in 2022. Will you make a contribution today?

Give Now